Last reviewed · How we verify
Non-antithrombotic group
Non-antithrombotic group is a Small molecule drug developed by OCEAN-SHD Study Group. It is currently FDA-approved.
This is a descriptive category rather than a specific drug, referring to medications that do not prevent blood clots through anticoagulation or antiplatelet mechanisms.
At a glance
| Generic name | Non-antithrombotic group |
|---|---|
| Sponsor | OCEAN-SHD Study Group |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
The 'Non-antithrombotic group' is a classification used in the OCEAN-SHD Study Group research to distinguish drugs that work through mechanisms other than inhibiting thrombosis. Without a specific drug name or mechanism identified, this represents a comparative category in clinical research rather than a defined therapeutic agent.
Approved indications
Common side effects
Key clinical trials
- Early Warning and Classification Model for Acute Non-traumatic Chest Pain
- AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (PHASE3)
- Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38) (NA)
- Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) (PHASE4)
- CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection (PHASE3)
- Effect of Oral Antiplatelet or Anticoagulant Drugs on Postoperative Bleeding Risk and Venous Closure Rate in Patients With Lower Extremity Varicose Veins After Radiofrequency Ablation
- A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial). (PHASE2)
- LAAO Versus NOAC in Patients with AF and PCI (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Non-antithrombotic group CI brief — competitive landscape report
- Non-antithrombotic group updates RSS · CI watch RSS
- OCEAN-SHD Study Group portfolio CI
Frequently asked questions about Non-antithrombotic group
What is Non-antithrombotic group?
How does Non-antithrombotic group work?
Who makes Non-antithrombotic group?
What development phase is Non-antithrombotic group in?
Related
- Manufacturer: OCEAN-SHD Study Group — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing